Investigational Drug Information for DWP16001
✉ Email this page to a colleague
What is the development status for investigational drug DWP16001?
DWP16001 is an investigational drug.
There have been 22 clinical trials for DWP16001.
The most recent clinical trial was a Phase 1 trial, which was initiated on May 25th 2021.
The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Endocrine System Diseases. The leading clinical trial sponsors are Daewoong Pharmaceutical Co. LTD. and [disabled in preview].
Summary for DWP16001
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 8 |
| WIPO Patent Applications | 3 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 1 (2021-05-25) |
| Vendors | 22 |
Recent Clinical Trials for DWP16001
| Title | Sponsor | Phase |
|---|---|---|
| Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus | Daewoong Pharmaceutical Co. LTD. | Phase 3 |
| To Evaluate the Effect of Food on the Safety and PK Characteristics of DWP16001 in Healthy Adult Volunteers | Daewoong Pharmaceutical Co. LTD. | Phase 1 |
| To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Function | Daewoong Pharmaceutical Co. LTD. | Phase 1 |
Clinical Trial Summary for DWP16001
Top disease conditions for DWP16001
Top clinical trial sponsors for DWP16001
US Patents for DWP16001
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
